Connect with us

Awareness

Turmeric Produces ‘Remarkable’ Recovery in Alzheimer’s Patients

Published

on

In Brief

  • The Facts:

    A study on patients with AD found that less than a gram of turmeric daily, taken for three months, resulted in 'remarkable improvements.'

  • Reflect On:

    Turmeric has been used in India for over 5,000 years, which is likely why still today both rural and urban populations have some of the lowest prevalence rates of Alzheimer's disease (AD) in the world.

This article was written by Sayer Ji, founder of Greenmedinfo.com where it was originally published. Posted here with permission.

advertisement - learn more

A diagnosis of Alzheimer’s disease (AD), sadly, has become a rite of passage in so-called developed countries. AD is considered the most common form of dementia, which is defined as a serious loss of cognitive function in previously unimpaired persons, beyond what is expected from normal aging.

A 2006 study estimated that 26 million people throughout the world suffer from this condition, and that by 2050, the prevalence will quadruple, by which time 1 in 85 persons worldwide will be afflicted with the disease.[1]

Given the global extent of the problem, interest in safe and effective preventive and therapeutic interventions within the conventional medical and alternative professions alike are growing.

Unfortunately, conventional drug-based approaches amount to declaring chemical war upon the problem, a mistake which we have documented elsewhere, and which can result in serious neurological harm, as evidenced by the fact that this drug class carries an alarmingly high risk for seizures, according to World Health Organization post-marketing surveillance statistics.[i][2]

What the general public is therefore growing most responsive to is using time-tested, safe, natural and otherwise more effective therapies that rely on foods, spices and familiar culinary ingredients.

advertisement - learn more

Remarkable Recoveries Reported after Administration of Turmeric

Late last year, a remarkable study was published in the journal Ayu titiled “Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia.” [ii] Researchers described three patients with Alzheimer’s disease whose behavioral symptoms were “improved remarkably” as a result of consuming 764 milligram of turmeric (curcumin 100 mg/day) for 12 weeks. According to the study:

All three patients exhibited irritability, agitation, anxiety, and apathy, two patients suffer from urinary incontinence and wonderings. They were prescribed turmeric powder capsules and started recovering from these symptoms without any adverse reaction in the clinical symptom and laboratory data.

After only 3 months of treatment, both the patients’ symptoms and the burden on their caregivers were significantly decreased.

The report describes the improvements thusly:

In one case, the Mini-Mental State Examination (MMSE) score was up five points, from 12/30 to 17/30. In the other two cases, no significant change was seen in the MMSE; however, they came to recognize their family within 1 year treatment. All cases have been taking turmeric for more than 1 year, re-exacerbation of BPSD was not seen.

This study illustrates just how powerful a simple natural intervention using a time-tested culinary herb can be. Given that turmeric has been used medicinally and as a culinary ingredient for over 5,000 years in Indian culture, even attaining the status of a ‘Golden Goddess,’ we should not be surprised at this result. Indeed, epidemiological studies of Indian populations reveal that they have a remarkably lower prevalence of Alzheimer’s disease relative to Western nations, [3] and this is true for both rural and more “Westernized” urban areas of India.[4]

Could turmeric be a major reason for this?

Turmeric’s Anti-Alzheimer’s Properties

The GreenMedInfo.com database now contains a broad range of published studies on the value of turmeric, and its primary polyphenol curcumin (which gives it its golden hue), for Alzheimer’s disease prevention and treatment.*

While there are 114 studies on our Turmeric research page indicating turmeric has a neuroprotective set of physiological actions, [5] 30 of these studies are directly connected to turmeric’s anti-Alzheimer’s disease properties.**

Two of these studies are particularly promising, as they reveal that curcumin is capable of enhancing the clearance of the pathological amyloid–beta plaque in Alzheimer’s disease patients,[6] and that in combination with vitamin D3 the neurorestorative process is further enhanced.[7] Additional preclinical research indicates curcumin (and its analogs) has inhibitory and protective effects against Alzheimer’s disease associated β-amyloid proteins.[8] [9] [10]

Other documented Anti-Alzheimer’s mechanisms include:

  • Anti-inflammatory: Curcumin has been found to play a protective role against β-amyloid protein associated inflammation.[11]
  • Anti-oxidative: Curcumin may reduce damage via antioxidant properties.[12]
  • Anti-cytotoxic: Curcumin appears to protect against the cell-damaging effects of β-amyloid proteins.[13] [14]
  • Anti-amyloidogenic: Turmeric contains a variety of compounds (curcumin, tetrahydrocurcumin, demethoxycurcumin and bisdemethoxycurcumin) which may strike to the root pathological cause of Alzheimer’s disease by preventing β-amyloid protein formation.[15] [16] [17] [18]
  • Neurorestorative: Curcuminoids appear to rescue long-term potentiation (an indication of functional memory) impaired by amyloid peptide, and may reverse physiological damage by restoring distorted neurites and disrupting existing plaques. [19] [20]
  • Metal-chelating properties: Curcumin has a higher binding affinity for iron and copper rather than zinc, which may contribute to its protective effect in Alzheimer’s disease, as iron-mediated damage may play a pathological role.[21] [22]

Just The Tip of the Medicine Spice Cabinet

The modern kitchen pantry contains a broad range of anti-Alzheimer’s disease items, which plenty of science now confirms. Our Alzheimer’s research page contains research on 97 natural substances of interest. Top on the list, of course, is curcumin. Others include:

  • Coconut Oil: This remarkable substance contains approximately 66% medium chain triglycerides by weight, and is capable of improving symptoms of cognitive decline in those suffering from dementia by increasing brain-boosing ketone bodies, and perhaps more remarkably, within only one dose, and within only two hours.[23]
  • Cocoa: A 2009 study found that cocoa procyanidins may protect against lipid peroxidation associated with neuronal cell death in a manner relevant to Alzheimer’s disease.[24]
  • Sage: A 2003 study found that sage extract has therapeutic value in patients with mild to moderate Alzheimer’s disease.[25]
  • Folic acid: While most of the positive research on this B vitamin has been performed on the semi-synthetic version, which may have unintended, adverse health effects, the ideal source for this B vitamin is foliage, i.e. green leafy vegetables, as only foods provide folate. Also, the entire B group of vitamins, especially including the homocysteine-modulating B6 and B12,[26] may have the most value in Alzheimer’s disease prevention and treatment.
  • Resveratrol: this compound is mainly found in the Western diet in grapes, wine, peanuts and chocolate. There are 16 articles on our website indicating it has anti-Alzheimer’s properties.[27]

Other potent natural therapies include:

  • Gingko biloba: is one of the few herbs proven to be at least as effective as the pharmaceutical drug Aricept in treating and improving symptoms of Alzheimer’s disease.[28] [29]
  • Melissa offinalis: this herb, also known as Lemon Balm, has been found to have therapeutic effect in patients with mild to moderate Alzheimer’s disease.[30]
  • Saffron: this herb compares favorably to the drug donepezil in the treatment of mild-to-moderate Alzheimer’s disease.[31]

As always, the important thing to remember is that it is our diet and environmental exposures that largely determine our risk of accelerated brain aging and associated dementia. Prevention is an infinitely better strategy, especially considering many of the therapeutic items mentioned above can be used in foods as spices. Try incorporating small, high-quality culinary doses of spices like turmeric into your dietary pattern, remembering that ‘adding it to taste,’ in a way that is truly enjoyable, may be the ultimate standard for determining what a ‘healthy dose’ is for you.

Notes:

*This statement is not meant to be used to prevent, diagnosis, treat, or cure a disease; rather, it is a statement of fact: the research indexed on our database indicates it

**Our professional database users are empowered to employ the ‘Advanced Database Options’ listed on the top of the Turmeric research page and after clicking the function “Sort Quick Summaries by Title Alphabetically” under “Available Sorting Options” they can quickly retrieve an alphabetical list of all 613 diseases relevant to the Turmeric research, and then choosing the “Focus” articles selection to the right of the “Alzheimer’s disease” heading to see only the 30 study abstracts relevant to the topic.


References

[1] Ron Brookmeyer, Elizabeth Johnson, Kathryn Ziegler-Graham, H Michael Arrighi. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007 Jul ;3(3):186-91. PMID: 19595937

[2] Nozomi Hishikawa, Yoriko Takahashi, Yoshinobu Amakusa, Yuhei Tanno, Yoshitake Tuji, Hisayoshi Niwa, Nobuyuki Murakami, U K Krishna. Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia. Ayu. 2012 Oct ;33(4):499-504. PMID: 23723666

[3] V Chandra, R Pandav, H H Dodge, J M Johnston, S H Belle, S T DeKosky, M Ganguli. Incidence of Alzheimer’s disease in a rural community in India: the Indo-US study. Neurology. 2001 Sep 25 ;57(6):985-9. PMID: 11571321

[4] GreenMedInfo.com, Declaring Chemical Warfare Against Alzheimer’s.

[5] GreenMedInfo.com, Turmeric’s Neuroprotective Properties (114 study abstracts)

[6] Laura Zhang, Milan Fiala, John Cashman, James Sayre, Araceli Espinosa, Michelle Mahanian, Justin Zaghi, Vladimir Badmaev, Michael C Graves, George Bernard, Mark Rosenthal. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2006 Sep;10(1):1-7. PMID: 16988474

[7] Ava Masoumi, Ben Goldenson, Senait Ghirmai, Hripsime Avagyan, Justin Zaghi, Ken Abel, Xueying Zheng, Araceli Espinosa-Jeffrey, Michelle Mahanian, Phillip T Liu, Martin Hewison, Matthew Mizwickie, John Cashman, Milan Fiala. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2009 Jul;17(3):703-17. PMID: 19433889

[8] Hongying Liu, Zhong Li, Donghai Qiu, Qiong Gu, Qingfeng Lei, Li Mao. The inhibitory effects of different curcuminoids onβ-amyloid protein, β-amyloid precursor protein and β-site amyloid precursor protein cleaving enzyme 1 in swAPP HEK293 cells. Int Dent J. 1996 Feb;46(1):22-34. PMID: 20727383

[9] Shilpa Mishra, Mamata Mishra, Pankaj Seth, Shiv Kumar Sharma. Tetrahydrocurcumin confers protection against amyloidβ-induced toxicity. Neuroreport. 2010 Nov 24. Epub 2010 Nov 24. PMID: 21116204

[10] Xiao-Yan Qin, Yong Cheng, Long-Chuan Yu. Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons. Neurosci Lett. 2010 Aug 9;480(1):21-4. PMID: 20638958

[11] Hong-Mei Wang, Yan-Xin Zhao, Shi Zhang, Gui-Dong Liu, Wen-Yan Kang, Hui-Dong Tang, Jian-Qing Ding, Sheng-Di Chen. PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. J Alzheimers Dis. 2010;20(4):1189-99. PMID: 20413894

[12] G P Lim, T Chu, F Yang, W Beech, S A Frautschy, G M Cole. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001 Nov 1;21(21):8370-7. PMID: 11606625

[13] Xiao-Yan Qin, Yong Cheng, Long-Chuan Yu. Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons. Neurosci Lett. 2010 Aug 9;480(1):21-4. PMID: 20638958

[14] D S Kim, S Y Park, J K Kim. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett. 2001 Apr 27;303(1):57-61. PMID: 11297823

[15] R Douglas Shytle, Paula C Bickford, Kavon Rezai-zadeh, L Hou, Jin Zeng, Jun Tan, Paul R Sanberg, Cyndy D Sanberg, Bill Roschek, Ryan C Fink, Randall S Alberte. Optimized turmeric extracts have potent anti-amyloidogenic effects. Curr Alzheimer Res. 2009 Dec;6(6):564-71. PMID: 19715544

[16] Fusheng Yang, Giselle P Lim, Aynun N Begum, Oliver J Ubeda, Mychica R Simmons, Surendra S Ambegaokar, Pingping P Chen, Rakez Kayed, Charles G Glabe, Sally A Frautschy, Gregory M Cole. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Neurochem Int. 2009 Mar-Apr;54(3-4):199-204. Epub 2008 Nov 30. PMID: 15590663

[17] Can Zhang, Andrew Browne, Daniel Child, Rudolph E Tanzi. Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. Gastroenterology. 2006 Jan;130(1):120-6. PMID: 20622013

[18] Ranjit K Giri, Vikram Rajagopal, Vijay K Kalra. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem. 2004 Dec;91(5):1199-210. PMID: 15569263

[19] Touqeer Ahmed, Anwarul-Hassan Gilani, Narges Hosseinmardi, Saeed Semnanian, Syed Ather Enam, Yaghoub Fathollahi. Curcuminoids rescue long-term potentiation impaired by amyloid peptide in rat hippocampal slices. Synapse. 2010 Oct 20. Epub 2010 Oct 20. PMID: 20963814

[20] M Garcia-Alloza, L A Borrelli, A Rozkalne, B T Hyman, B J Bacskai. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem. 2007 Aug;102(4):1095-104. Epub 2007 Apr 30. PMID: 17472706

[21] Larry Baum, Alex Ng. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. J Alzheimers Dis. 2004 Aug;6(4):367-77; discussion 443-9. PMID: 15345806

[22] Silvia Mandel, Tamar Amit, Orit Bar-Am, Moussa B H Youdim. Iron dysregulation in Alzheimer’s disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents. Prog Neurobiol. 2007 Aug;82(6):348-60. Epub 2007 Jun 19. PMID: 17659826

[23] Mark A Reger, Samuel T Henderson, Cathy Hale, Brenna Cholerton, Laura D Baker, G S Watson, Karen Hyde, Darla Chapman, Suzanne Craft. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004 Mar;25(3):311-4. PMID: 15123336

[24] Eun Sun Cho, Young Jin Jang, Nam Joo Kang, Mun Kyung Hwang, Yong Taek Kim, Ki Won Lee, Hyong Joo Lee. Cocoa procyanidins attenuate 4-hydroxynonenal-induced apoptosis of PC12 cells by directly inhibiting mitogen-activated protein kinase kinase 4 activity. Free Radic Biol Med. 2009 May 15;46(10):1319-27. Epub 2009 Feb 25. PMID: 19248828

[25] S Akhondzadeh, M Noroozian, M Mohammadi, S Ohadinia, A H Jamshidi, M Khani. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther. 2003 Feb;28(1):53-9. PMID: 12605619

[26] Celeste A de Jager, Abderrahim Oulhaj, Robin Jacoby, Helga Refsum, A David Smith. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry. 2011 Jul 21. Epub 2011 Jul 21. PMID: 21780182

[27] GreenMedInfo.com, Resveratrol’s Anti-Alzheimer’s properties

[28] S Yancheva, R Ihl, G Nikolova, P Panayotov, S Schlaefke, R Hoerr,. Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer’s disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. Aging Ment Health. 2009 Mar;13(2):183-90. PMID: 19347685

[29] M Mazza, A Capuano, P Bria, S Mazza. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer’s dementia in a randomized placebo-controlled double-blind study. Eur J Neurol. 2006 Sep;13(9):981-5. PMID: 16930364

[30] S Akhondzadeh, M Noroozian, M Mohammadi, S Ohadinia, A H Jamshidi, M Khani. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):863-6. PMID: 12810768

[31] Shahin Akhondzadeh, Mehdi Shafiee Sabet, Mohammad Hossein Harirchian, Mansoreh Togha, Hamed Cheraghmakani, Soodeh Razeghi, Seyyed Shamssedin Hejazi, Mohammad Hossein Yousefi, Roozbeh Alimardani, Amirhossein Jamshidi, Shams-Ali Rezazadeh, Aboulghasem Yousefi, Farhad Zare, Atbin Moradi, Ardalan Vossoughi. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology (Berl). 2010 Jan;207(4):637-43. Epub 2009 Oct 20. PMID: 19838862

Sayer Ji is founder of Greenmedinfo.com, a reviewer at the International Journal of Human Nutrition and Functional Medicine, Co-founder and CEO of Systome Biomed, Vice Chairman of the Board of the National Health Federation, Steering Committee Member of the Global Non-GMO Foundation.

Link to the original article.

For more information from Greenmedinfo, sign up for their Newsletter here.

Start Your Free 7 Day Trial To CETV!

Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network!

You can stream conscious media 24/7 and enjoy mind-expanding interviews, original shows, and documentaries and guided programs.

Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media that you won't see anywhere else.

Advertisement
advertisement - learn more

Awareness

The “Inconvenient Truth” About Mental Illness & Prescription Medications

Published

on

In Brief

  • The Facts:

    Prescription drug sales and deaths are at an all time high. With side effects and dangers, and a lack of safety testing in some cases, are they always the best and only option for mental health treatment?

  • Reflect On:

    Why are alternative treatments for mental health lacking? Is it because they are not as effective as prescription medication or do not turn a profit?

A worrisome trend has emerged in the last few decades that many physicians are choosing to ignore: As the amount of psychiatric drug prescriptions increase, our mental health declines. It’s time we swallow the hard pill and ask ourselves, are psychiatrists doing more harm than good?

I know that, to some of you, this question seems absurd. Why would licensed medical practitioners purposefully harm their patients? But that isn’t really what’s happening here, as the issue relates more to the over-prescription and misuse of mental health drugs, and the corporately funded miseducation that prompts this behaviour, than any malicious intentions on the part of individual people.

The “Inconvenient Truth” About Mental Illness and Prescriptions

In 2013, approximately 17% of Americans were prescribed at least one mental health drug, in comparison to only 10% in 2011. The amount of people on psychiatric prescription drugs has drastically increased over the past 10 years and now 12% of adult Americans are taking some form of antidepressants alone (source).

It’s not just adults affected by the over-prescription of these drugs; according to the Centers for Disease Control and Prevention (CDC), approximately 11% of children between the ages of 4 and 17 were diagnosed with ADHD as of 2011. However, the American Psychiatric Association maintains that even though only 5% of American children suffer from the disorder, the diagnosis is actually given to around 15% of American children. This number has been steadily rising, jumping from 7.8% in 2003 to 9.5% in 2007. The simple reason for this increase? Profit.

However, despite the fact that the number of mental health drugs prescribed increases every year, our mental health has actually decreased. The amount of people who are considered to be so disabled by mental illness that they require Supplemental Security Income (SSI) or Social Security Disability Insurance (SSDI) has increased by almost two and a half times between 1987 and 2007, from one in 184 Americans to one in seventy-six. Not surprisingly, the rise in the number of children affected by this is even worse, with a thirty-five-fold increase in that same timeframe (source). So, if the number of prescriptions are increasing, why is our mental health declining?

This phenomenon is what Thomas Insel, former Director of the National Institute of Mental Health, refers to as the “inconvenient truth” of mental illness. Suicide rates per 100,000 people have reached a 30-year high and substance abuse, especially with opiates, has become a national epidemic.

advertisement - learn more

Edmund S. Higgins, MD and Professor of Psychiatry at the Medical University of South Carolina, explains, “More people are getting treatment and taking medications today than ever before, so what is going on? I would argue that a lack of precision and objectivity in diagnosing and treating mental illness has stalled our progress.” Furthermore, Big Pharma has played a crucial role in creating the mental health drug epidemic.

Big Pharma’s Role in Increasing Prescriptions

This seems to be the general consensus of the North American population: If an advertisement or a misinformed MD says, “There’s a pill for that,” you take it. Our reliance on pharmaceutical drugs didn’t form by accident, however; it was carefully planned and funded by Big Pharma. The pharmaceutical industry manufactured it by heavily advertising drugs, bribing physicians, and funding health studies.

Big Pharma has done an excellent job of feeding the public propaganda through advertisements and education, as the more pills you take, the more money they make. The pharmaceutical industry has played a substantial role in increasing the amount of prescriptions and overall diagnoses of A.D.H.D. in the U.S. (read an article I wrote about this here) and other mental health illnesses. As Dr. Irwin Savodnik of UCLA explains, “The very vocabulary of psychiatry is now defined at all levels by the pharmaceutical industry.”

Doctors typically use the knowledge from the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM) to diagnose and treat mental illness. But the DSM has had its fair share of criticism, as it favours the use of pharmaceutical drugs over therapy and other healing modalities. Associate Clinical Professor of Psychiatry at Tufts University School of Medicine and Editor-in-Chief of The Carlat Psychiatry Report Daniel J. Carlat, M.D, criticized the DSM, stating, “In psychiatry, many diseases are treated equally well with medication or therapy, but the guidelines tend to be biased toward medication.”

Holistic mental health practitioner Dr. Tyler Woods further explains:

The DSM tends to pathologize normal behaviors. For instance, the label “Anxiety Disorder” can be given as a result of some kinds of normal and rather healthy anxieties but the DSM will have experts view it and treat it as mental illness. In addition simple shyness can be seen and treated as “Social Phobia”, while spirited and strong willed children as “Oppositional Disorder”. Consequently, many psychotherapists, regardless of their theoretical orientations, tend to follow the DSM as instructed. (source)

In fact, Big Pharma has played a significant role in manufacturing our very definitions of mental illnesses and how they form in the first place. For example, the U.S. considers A.D.H.D. a neurological disorder whose symptoms are the result of biological disfunction or a chemical imbalance in the brain, much like many other mental disorders. However, other countries such as France see these mental disorders, including A.D.H.D., as a social context issue rather than a biological one, with many contributing factors and recommended treatments other than drugs. Dr. Marcia Angell, a physician, author, and the Editor-in-Chief of the New England Journal of Medicine, states:

When it was found that psychoactive drugs affect neurotransmitter levels in the brain, as evidenced mainly by the levels of their breakdown products in the spinal fluid, the theory arose that the cause of mental illness is an abnormality in the brain’s concentration of these chemicals that is specifically countered by the appropriate drug. For example, because Thorazine was found to lower dopamine levels in the brain, it was postulated that psychoses like schizophrenia are caused by too much dopamine. . . .

That was a great leap in logic . . . It was entirely possible that drugs that affected neurotransmitter levels could relieve symptoms even if neurotransmitters had nothing to do with the illness in the first place (and even possible that they relieved symptoms through some other mode of action entirely).

Why Pills Cannot Solve All of Our Problems

I’m not saying that you shouldn’t take prescription medication for mental illness; that’s something that you and your doctor should decide. However, if your doctor fails to address any other means of dealing with your mental health, always choosing pills first rather than as a last or even second resort, then perhaps you should think about finding a doctor who understands the benefits of at least considering alternative options.

It’s important to note that even if prescription drugs are the reason our mental health is worsening, they’re certainly not the only reason. We’ve increased our amount of time spent using technology, staying indoors, and being sedentary, as well as worsened our diets and overall physical health with fast food, chemicals, toxins, animal products, and more — all of which may contribute to this decline in mental health.

However, there’s no denying the fact that Big Pharma has had a tangible and worrisome role in the psychiatric drug epidemic. Medical journalist and Pulitzer Prize nominee Robert Whitaker addresses this “inconvenient truth” by using depression as an example. Depression used to be considered a self-limiting illness that, even in severe situations where a patient requires hospitalization, could be cured within six to eight months. Very rarely would patients relapse, and if they did it would typically be many years later.

When antidepressants hit the market, our outlook on depression completely shifted. Even though antidepressants may have been created with good intentions, the reality is that patients taking these drugs are relapsing more quickly and more often. Whitaker explains that many patients on antidepressants will only recover partially in comparison to the full recoveries he’s seen in people who never took them in the first place.

In fact, only around 15% of those treated with antidepressants actually go into remission and maintain their mental health long-term. The other 85% are continuously relapsing or experience chronic depression.

It is clear that in many cases, we need to stop looking for outside help when it comes to our mental health. Our mental health is just that — it’s ours. It’s controlled by us, whether we like it or not. Many mental illnesses don’t stem from biological issues, contrary to what Big Pharma wants you to think, but are rather the result of different stressors in our lives. So, if we were able to connect with ourselves on a deeper level and actually get to the root of the problem, perhaps some of these disorders wouldn’t be so severe.

Related CE Content:

Study Finds Turmeric Is As Effective As Prozac For Treating Depression

Almost No Children In France Are Medicated For ADHD: Here’s How They Define & Treat It

Professor Outlines The “Surprisingly Dramatic” Role That Nutrition Plays In Treating & Curing Mental Illness

Picture source. 

 

Start Your Free 7 Day Trial To CETV!

Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network!

You can stream conscious media 24/7 and enjoy mind-expanding interviews, original shows, and documentaries and guided programs.

Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media that you won't see anywhere else.

Continue Reading

Awareness

Fact-Checking The Fact Checkers About Coronavirus & Vitamin C Treatment – Is It Really “Fake News”?

Published

on

In Brief

  • The Facts:

    The idea that vitamin C can have some potential in treating and preventing the new coronavirus is being invalidated and even labelled as 'fake news' by some. If this was true, why are clinical trials for intravenous vitamin C underway in China?

  • Reflect On:

    Can we rely on our medical system to provide the best possible solutions, or will profit always come first? How much trust have they lost among the general population over the years?

An article published by LiveScience, a mainstream science website, states that “Vitamin C is extremely unlikely to help people fight off the new coronavirus.” Mainstream media has been attacking the idea that vitamin C could have some potential to prevent or even treat the new coronavirus. This rhetoric follows statements that have come out from government health regulatory agencies. Take Health Canada, for example, who recently tweeted that there are no natural health products “that are authorized to protect against” the new coronavirus. They go on to state that “any claims otherwise are false.”

This is a problem that’s plagued our world since the introduction of the mainstream medical industry. Arnold Seymour Relman, a former Harvard professor of medicine and former Editor-in-Chief of The New England Medical Journal, states this problem clearly: 

“The medical profession is being bought by the pharmaceutical industry, not only in terms of the practice of medicine, but also in terms of teaching and research. The academic institutions of this country are allowing themselves to be the paid agents of the pharmaceutical industry. I think it’s disgraceful.” (source)

The question people need to be asking is, where does government loyalty lie? Perhaps it’s with the industry that spends two times more than any other lobby in congress. This is why nothing can be used as a treatment, for any disease, unless it’s patented and presented to us by a pharmaceutical company. “Alternative” treatments are always branded as ‘fake’ and even ‘dangerous’.

Vitamin C Trials and Treatment

This recent coronavirus outbreak might provide the latest insight into this matter. Going back to the statement above from LiveScience that states “Vitamin C is extremely unlikely to help people fight off the new coronavirus”: if this is really the case, then why would China start multiple clinical trials to examine whether or not intravenous vitamin C can be helpful in treating people with coronavirus?

The article in LiveScience did not acknowledge this originally, but they added an update stating that researchers at Zhongnan Hospital of Wuhan University had launched a clinical trial with 140 patients in February to test whether ultrahigh doses of vitamin C, delivered intravenously, could treat the viral infection more effectively than a placebo. The test group will receive infusions twice a day for seven days, with each infusion containing 12g of vitamin C. (The daily recommendation for an adult man is only 90mg.) The trial will be completed in September, and no results are yet available, according to ClinicalTrials.gov.

advertisement - learn more

That being said, Dr. Richard Cheng, MD, has been updating everyone via his YouTube channel about vitamin C treatment cases out of China. We have been covering his updates as he is in direct contact with this treatment and isn’t simply an armchair scientist at the moment. We feel at this time this is a very important detail as he is seeing and hearing results first hand, not simply theoretically. Dr. Cheng is a US board-certified anti-aging specialist. He claims that vitamin C is now in the Shanghai Government treatment plan.

Dr. Cheng was paramount in bringing high-dose vitamin C to the table as part of potential treatment and prevention measures. Unfortunately in the West, this option is still being denied by much of mainstream media and governments are not talking about it. Instead, it’s fear and chaos which we do not feel helps anyone to stay healthy or get better.

According to Cheng, 50 moderate to severe cases of Covid-19 infection were treated with high-dose IVC. Dosing of IVC ranged from 10,000 – 20,000 mg a day for 7-10 days, with 10,000 mg for moderate cases and 20,000 for more severe cases. The first bit of good news was that all patients who received IVC improved and there has been no mortality. Secondly, as compared to the average of a 30-day hospital stay for all Covid-19 patients, those patients who received high dose IVC had a hospital stay of about 3-5 days shorter than the other patients.

In one particularly severe case where the patient was deteriorating rapidly, an extra dose of 50,000 mg IVC was given over a period of 4 hours and it caused the patient’s pulmonary (oxygenation index) status to stabilize and improve as the critical care team observed in real time. You can watch all of the updates from Cheng via his Youtube Channel.

Related CE Articles: Good Coronavirus News: High Dose Vitamin C Shows Good Results In China Hospital

How To Take Vitamin C Orally. It MAY Help Protect Against Viruses

Enjoy This Free Conscious Breathing Course To Bring Peace & Heightened Immunity

So, at the very worst we can officially say that we don’t know, but there are some positive signs thus far, which again, is obvious due to the fact that they would even begin a clinical trial, and the explanation as to why such a hypothesis exists is explained within the clinical trial website listed earlier. To say that it’s false or extremely unlikely is, in fact, the false news.

Looking For Some Vitamin C?

For anyone looking for a high-quality vitamin C, we have been using and recommending liposomal vitamin C. There are many brands out there. We are using this one from PuraThrive as it is very high quality and has an incredible clinically proven absorption rate.

The Takeaway

Is it really safe and truthful to make the claim that “Vitamin C is extremely unlikely to help people fight off the new coronavirus”? This is the rhetoric we’ve been hearing from mainstream media sources for quite a while, and articles posted on social media providing evidence that it may show some promise are being flagged by fact checkers as fake news. Again, if it was extremely unlikely, why use so many resources that are required to start a clinical trial in the first place? Why are we getting a completely different perspective from an MD in China that’s providing the world with updates? These are important questions to ask, as this example simply highlights one of the biggest problems that plagues the mainstream medical industry, which is a complete denial of the potential of natural treatments. Because these treatments cannot be patented and turned a profit, they are ridiculed, ignored and brushed off.

Start Your Free 7 Day Trial To CETV!

Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network!

You can stream conscious media 24/7 and enjoy mind-expanding interviews, original shows, and documentaries and guided programs.

Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media that you won't see anywhere else.

Continue Reading

Alternative News

Coronavirus Will Slow Down & Humanity Will Survive, Says Biophysicist Michael Levitt

Published

on

In Brief

  • The Facts:

    Biophysicist Michael Levitt explains his coronavirus predictions and why he thinks the spread will slow down quite rapidly.

  • Reflect On:

    With so much hysteria floating around, what can you do to keep your self calm and at peace?

There are so many theories floating around about the coronavirus right now and what’s going to happen. The truth is, nobody knows. It’s quite clear that a large majority of the population have lost their trust in government, which is why people continue to search for alternative sources of information with regards to the origin of this virus, potential treatments and what could be in the cards for humanity next. At this point, it seems that nobody really knows what happens, and at the deepest levels, collective consciousness determines our path, nothing else. How we perceive, act, and react to what is happening right now determines our future.

I do believe there is a lot of unnecessary hysteria going on right now. That doesn’t mean precautions shouldn’t be taken, but what’s happening right now may be going a little overboard. Situations like this are often taken advantage of politically, economically and financially, and some people have proposed that the ones who ‘created the problem’ are going to ‘sell the pill.’  I don’t want to get into so called ‘conspiracy theories’ with this article, but there is definitely lots to think about when it comes to the virus.

Right now, it seems that the majority of people who have the virus are recovering quite well, and that there is greater concern for elderly people and those who already have underlying health issues. For example, a recent article in Bloomberg titled, “99% of Those Who Died From Virus Had Other Illness, Italy Says,” illustrates that the state of one’s immune system and overall health determines morbidity and mortality, and likely your susceptibility to infection in the first place.

More than 99% of Italy’s coronavirus fatalities were people who suffered from previous medical conditions, according to a study by the country’s national health authority…The Rome-based institute has examined medical records of about 18% of the country’s coronavirus fatalities, finding that just three victims, or 0.8% of the total, had no previous pathology. Almost half of the victims suffered from at least three prior illnesses and about a fourth had either one or two previous conditions. More than 75% had high blood pressure, about 35% had diabetes and a third suffered from heart disease.”

Some Good News

According biophysicist Michael Levitt, a Nobel laureate who teaches structural biology at Stanford University, the virus will pass, and all will be as it was. Levitt became quite a popular name across China. He offered the Chinese public some reassurance during the peak of the outbreak there, as he had determined, after investigating and crunching some numbers, that the virus will come to a halt.

Obviously, it’s spreading quite rapidly right now, so seeing how it may slow down might be hard for some people, but according to what Levitt saw from the numbers in China, other countries should also follow the same trend.

advertisement - learn more

The calming messages Levitt sent to his friends in China were translated into Chinese and passed from person to person, making him a popular subject for interviews in the Asian nation. His forecasts turned out to be correct: the number of new cases reported each day started to fall as of February 7. A week later, the mortality rate started falling as well….Levitt avoids making global forecasts. In China, he said, the number of new infections will soon reach zero, and South Korea is past the median point and can already see the end. Regarding the rest of the world, it is still hard to tell, he said. “It will end when all those who are sick will only meet people they have already infected. The goal is not to reach the situation the cruise ship experienced.”

Levitt pointed out that the rate of infection of the virus in the Hubei province in China increased by 30 percent each day. According to him, the entire world should have been infected within 90 days, but obviously this didn’t happen, and hasn’t happened.

When Levitt started analyzing the data on February 1, Hubei had 1,800 new cases each day and within six days this number reached 4,700, he said. “And then, on February 7, the number of new infections started to drop linearly and did not stop. A week later, the same happened with the number of the deaths. This dramatic change in the curve marked the median point and enabled better prediction of when the pandemic will end. Based on that, I concluded that the situation in all of China will improve within two weeks. And, indeed, now there are very few new infection cases.”

Levitt compared the situation to bank interest—if on the first day a person receives an interest rate of 30% on their savings, the next day of 29%, and so forth, “you understand that eventually, you will not earn very much.”

Originally Levitt said that coronavirus patients in China infected on average 2.2 people a day, which would be exponential growth that would lead to nothing but disaster. But then the rates started dropping and China has recently reported that new daily infections are now close to zero. “The fact that the infection rate is slowing down means the end of the pandemic is near,” he said. You can read more about why he feels the way he does, and his entire explanation here.

Basically, self-quarantine and social distancing really helps, as well as keeping our social circles to those who we usually interact with the same. All of the measures that are currently in places are no doubt bound to ‘flatten the curve,’ so there is no doubt that humanity is heading in the right direction and has hopefully already weathered the worst part of the storm.

More Good News

It looks like a treatment program of about 50 patients in China has shown positive results from high dose Vitamin C treatment of COVID-19. Last month, the US National Library of Medicine posted the information about their clinical trials on their website. The title of one of the trials is “Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia.” The sponsor is ZhiYong Peng, and the responsible party is Zhongnan Hospital in Wuhan University (ZNWU).

Dr. Richard Cheng has been updating everyone via his YouTube channel about vitamin C treatment cases out of China. We have been covering his updates as he is in direct contact with this treatment and isn’t simply an armchair scientist at the moment. We feel at this time this is a very important detail as he is seeing and hearing results first hand.

Dr. Cheng was paramount in bringing high dose vitamin C to the table as part of potential treatment and prevention measures in China. Unfortunately in the West, this option is still being denied by much of mainstream media and governments are not talking about it. Instead, it’s fear and chaos which we do not feel serves anyone to stay healthy or get better. I believe this is a great aspect of this journey to reflect on, as it tells us where loyalties lie when it comes to government and pharma. It also illustrates the agenda for creating a fear and separation culture as opposed to unity.

A group of medical doctors, healthcare providers and scientists met online March 17, 2020, to discuss the use of high dose intravenous vitamin C (IVC) in the treatment of moderate to severe cases of Covid-19 patients. Dr. Enqian Mao was in attendance. He is the chief of emergency medicine department at Ruijin Hospital, a major hospital in Shanghai, affiliated with the Joatong University College of Medicine. Dr. Mao is also a member of the Senior Expert Team at the Shanghai Public Health Center, where all Covid-19 patients have been treated. You can read more about that and watch Dr. Cheng’s video, here.

For anyone looking for a high-quality vitamin C, we have been using and recommending liposomal vitamin C. There are many brands out there. We are using this one from PuraThrive as it is very high quality and has an incredible clinically proven absorption rate.

Some Thoughts on Diet & Nutrition

It’s quite a head-scratcher why media in the West mentions nothing about vitamin C, and when they do, they simply ridicule the idea that it has any potential to be effective. Furthermore, there is no mention about the importance of diet and nutrition and the role nutrition can play when it comes to boosting the immune system. It truly makes no sense. It really goes to show how close of a relationship government has with industry, which now spends twice as much as any other lobby does in congress.  When it comes to health care, is it really about the best possible way to heal people, or the best possible way to heal people that provides profit?  It would be great to see health leaders come on the news and provide information on how one can strengthen their immune system through the use of foods, herbs etc. This would also contribute to lessening anxiety instead of constantly hearing “there is no treatment.” Based on what we are seeing happen in China, this statement is simply not true.

Start Your Free 7 Day Trial To CETV!

Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network!

You can stream conscious media 24/7 and enjoy mind-expanding interviews, original shows, and documentaries and guided programs.

Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media that you won't see anywhere else.

Continue Reading
advertisement - learn more
advertisement - learn more

Video

Pod

Elevate your inbox and get conscious articles sent directly to your inbox!

Choose your topics of interest below:

You have Successfully Subscribed!